Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 billion euros ($2.15-$5.38 billion) in peak sales potential, and three “pipeline-in-a-product” assets with a potential of more than 5 billion euros in peak sales, Sanofi said., The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 billion euros ($2.15-$5.38 billion) in peak sales potential, and three “pipeline-in-a-product” assets with a potential of more than 5 billion euros in peak sales, Sanofi said., , Read More

Leave a Reply

Your email address will not be published.